Value of second-trimester uterine artery pulsatility index in pregnancies with systemic lupus erythematosus and/or antiphospholipid syndrome

References

• Seoane-Mato D, Sánchez-Piedra C, Silva-Fernández L, et al. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): aims and methodology. Reumatol Clin. 2019;15(2):90–96.
   PubMed Web of Science ®Google Scholar
• Murphy G, Isenberg D. Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology. 2013;52(12):2108–2115.
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.
   PubMed Web of Science ®Google Scholar
• Orera L, Orts JA, Zúñiga A. Actualización del síndrome antifosfolipídico. Med Clin. 2003;121(12):459–471.
   PubMedGoogle Scholar
• Scott JR. Risks to the children born to mothers with autoimmune diseases. Lupus. 2002;11(10):655–660.
   PubMed Web of Science ®Google Scholar
• Clowse MEB, Jamison M, Myers E, et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199(2):127.e1–127.e6.
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: ten questions and some answers. Lupus. 2008;17(5):416–420.
   PubMed Web of Science ®Google Scholar
• Baer AN, Witter FR, Petri M. Lupus and pregnancy. Obstet Gynecol Surv. 2011; 66(10):639–653.
   PubMed Web of Science ®Google Scholar
• Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 2013;27(3):435–447.
   PubMed Web of Science ®Google Scholar
• Doria A, Tincani A, Lockshin M. Challenges of lupus pregnancies. Rheumatology. 2008;47(Supplement 3):iii9–12.
   PubMedGoogle Scholar
• Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, et al.; (EUROAPS Study Group Collaborators). The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 247 consecutive cases. Autoimmun Rev. 2015;14(5):387–395.
   PubMed Web of Science ®Google Scholar
• Saccone G, Berghella V, Maruotti GM, et al. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol. 2017;216(5):525.e1–525.e12.
   PubMed Web of Science ®Google Scholar
• Högdén A, Antovic A, Berg E, et al. Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile. Lupus. 2019;28(7):868–877.
   PubMed Web of Science ®Google Scholar
• Hernandez-Andrade E, Brodszki J, Lingman G, et al. Uterine artery score and perinatal outcome. Ultrasound Obstet Gynecol. 2002;19(5):438–442.
   PubMed Web of Science ®Google Scholar
• Stampalija T, Gyte GM, Alfirevic Z. Utero-placental Doppler ultrasound for improving pregnancy outcome. Cochrane Database Syst Rev. 2010;9:CD008363.
   PubMed Web of Science ®Google Scholar
• Benifla JL, Tchobroutsky C, Uzan M, et al. Predictive value of uterine artery velocity waveforms in pregnancies complicated by systemic lupus erythematosus and the antiphospholipid syndrome. Fetal Diagn Ther. 1992;7(3-4):195–202.
   PubMed Web of Science ®Google Scholar
• Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford). 2006;45(3):332–338.
   PubMed Web of Science ®Google Scholar
• Madazli R, Yuksel MA, Oncul M, et al. Obstetric outcomes and prognostic factors of lupus pregnancies. Arch Gynecol Obstet. 2014;289(1):49–53.
   PubMed Web of Science ®Google Scholar
• Pagani G, Reggia R, Andreoli L, et al. The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus. Prenat Diagn. 2015;35(5):447–452.
   PubMed Web of Science ®Google Scholar
• Petri M, Magder L. Classification criteria for systemic lupus erythematosus: a review. Lupus. 2004;13(11):829–837.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Almaraz ME, Herraiz I, Gómez-Arriaga PI, et al. The role of angiogenic biomarkers and uterine artery Doppler in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome. Pregnancy Hypertens. 2018;11:99–104.
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1):IX–XIV.
   PubMed Web of Science ®Google Scholar
• Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22(2):143–148.
   PubMed Web of Science ®Google Scholar
• Branch DW. Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus. 1994;3(4):275–280.
   PubMed Web of Science ®Google Scholar
• Gómez O, Figueras F, Fernández S, et al. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol. 2008;32(2):128–132.
   PubMed Web of Science ®Google Scholar
• Bundhun PK, Soogund MZS, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: A meta-analysis of studies published between years 2001-2016. J Autoimmun. 2017;79:17–27.
   PubMed Web of Science ®Google Scholar
• Shibata S, Sasaki T, Hirabayashi Y, et al. Risk factors in the pregnancy of patients with systemic lupus erythematosus: association of hypocomplementaemia with poor prognosis. Ann Rheum Dis. 1992;51(5):619–623.
   PubMed Web of Science ®Google Scholar
• Petri M, Howard D, Repke J, et al. The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am J Reprod Immunol. 1992;28(3-4):188–191.
   PubMed Web of Science ®Google Scholar
• Kutteh WH, Lyda EC, Abraham SM, et al. Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus. Fertil Steril. 1993;60(3):449–455.
   PubMed Web of Science ®Google Scholar
• Cortés-Hernández J, Ordi-Ros J, Paredes F, et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford)). 2002;41(6):643–650.
   PubMed Web of Science ®Google Scholar
• Smyth A, Oliveira GH, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5(11):2060–2068.
   PubMed Web of Science ®Google Scholar
• Mintz G, Niz J, Gutierrez G, et al. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol. 1986;13(4):732–739.
   PubMed Web of Science ®Google Scholar
• Capucci R, Pivato E, Carboni S, et al. The use of uterine artery Doppler as a predictive tool for adverse gestational outcomes in pregnant patients with autoimmune and thrombophilic disease. J Prenat Med. 2011; 5(2):54–58.
   PubMedGoogle Scholar
• Giancotti A, Spagnuolo A, Bisogni F, et al. Pregnancy and systemic lupus erythematosus: role of ultrasound monitoring. Eur J Obstet Gynecol Reprod Biol. 2011;154(2):233–234.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LC, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50(4):492–495.
   PubMed Web of Science ®Google Scholar
• Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet. 2019;145(S1):1–33.
   PubMed Web of Science ®Google Scholar
• Oancea M, Grigore M, Ciortea R, et al. Uterine artery doppler ultrasonography for first trimester prediction of preeclampsia in individuals at risk from low-resource settings. Medicina. 2020; 56(9):428.
   PubMedGoogle Scholar